Nonhuman primate model of schizophrenia using a noninvasive EEG method.
about
The dysconnection hypothesis (2016)Auditory dysfunction in schizophrenia: integrating clinical and basic features.Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophreniaThe qEEG Signature of Selective NMDA NR2B Negative Allosteric Modulators; A Potential Translational Biomarker for Drug DevelopmentFacilitative effect of repetitive presentation of one stimulus on cortical responses to other stimuli in macaque monkeys--a possible neural mechanism for mismatch negativityMismatch negativity in common marmosets: Whole-cortical recordings with multi-channel electrocorticograms.Electrophysiological Endophenotypes for SchizophreniaNeural Substrates of Auditory Emotion Recognition Deficits in Schizophrenia.Neurophysiological models for new treatment development in schizophrenia: early sensory approaches.Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia.Deviance-Related Responses along the Auditory Hierarchy: Combined FFR, MLR and MMN EvidenceEEG potentials associated with artificial grammar learning in the primate brainCortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia.NR2B Antagonist CP-101,606 Abolishes Pitch-Mediated Deviance Detection in Awake Rats.Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism.Ketamine Alters Outcome-Related Local Field Potentials in Monkey Prefrontal Cortex.Evolutionary origins of non-adjacent sequence processing in primate brain potentials.Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode PsychosisKetamine and phencyclidine: the good, the bad and the unexpected.Whole-scalp EEG mapping of somatosensory evoked potentials in macaque monkeysCeftriaxone reverses ketamine-induced lasting EEG and astrocyte alterations in juvenile mice.Mismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders.Connectivity, pharmacology, and computation: toward a mechanistic understanding of neural system dysfunction in schizophrenia.From Engrams to Pathologies of the Brain.The mechanisms and meaning of the mismatch negativity.Effects of transcranial direct current stimulation on the auditory mismatch negativity response and working memory performance in schizophrenia: a pilot study.Neural mechanisms of mismatch negativity dysfunction in schizophrenia.A hierarchy of responses to auditory regularities in the macaque brain.Cerebral responses to local and global auditory novelty under general anesthesiaComputational study of NMDA conductance and cortical oscillations in schizophrenia.Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle.A putative electrophysiological biomarker of auditory sensory memory encoding is sensitive to pharmacological alterations of excitatory/inhibitory balance in male macaque monkeys.Effects of an NMDA antagonist on the auditory mismatch negativity response to transcranial direct current stimulation.N-methyl-d-aspartate receptor antagonist ketamine impairs action-monitoring activity in the prefrontal cortex.Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine.NAPLIB: AN OPEN SOURCE TOOLBOX FOR REAL-TIME AND OFFLINE NEURAL ACOUSTIC PROCESSING.Early enhanced processing and delayed habituation to deviance sounds in autism spectrum disorder.Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.Magnetoencephalographic recording of auditory mismatch negativity in response to duration and frequency deviants in a single session in patients with schizophrenia.
P2860
Q26741916-E1AF93CE-6A98-47DB-919D-BB12F0E2DBC1Q26796401-AE3871B8-41BC-430F-9F39-77172995CC20Q27014120-01EC77F8-81C3-453F-BC71-2170CD83FCF8Q28551131-FDC7A866-680D-4C13-9A14-C9ED480D9E50Q28597531-FC2138CE-C2CA-4E26-9C6D-E2903D209F96Q28606533-9ABC9422-6172-480A-B823-8DFB685884F0Q30362188-5C255684-5E1B-4BC2-9DD2-8735CC079C63Q30384219-CEC8E24E-C640-4857-B416-FD514E3BF152Q30384452-7E7D0D0B-D329-43D1-BEBD-CD76B9297574Q30387378-32A103C4-3567-4BED-A706-728840212D9EQ30394589-215C0404-64F7-4FB6-BA16-64709D9D741CQ30403166-49BFC7D6-5B94-426A-ACF7-32991490B976Q30403543-092278A1-11CE-4886-A40B-46F4B872C199Q30426629-14902302-6213-4BCC-B2C4-BFAF5DD9B848Q30432782-E589D100-83C5-4E0A-BD45-17FDE05DFFDDQ30727742-2FFBEF14-BDBE-47C1-A3D5-A6BD05D6A0F4Q30758231-75DBA759-ECAE-4A32-B0F9-DE13C6A49DA4Q30828081-6D462E81-836B-4B45-83B2-3D64BAB9BB6CQ33720060-AD7A7BC2-5114-4AF8-BD09-DAE4BD2E2062Q34480719-1B6CE515-49A0-4B29-A8B3-52B944841ABDQ35830616-CB6BA61C-CB5A-42F1-A07D-CE1F10B70E66Q36248928-6B33DABE-EAD4-4D0E-83C8-BB0722AB9F0DQ37191789-6114C568-D0B3-412D-A13A-C6948319563EQ37412196-87E7892D-E227-4F13-9199-684FE730FC41Q37740652-F6D37E88-2070-4F67-B5B9-87B87BF8D3E9Q38166226-2A7EB243-D01E-416F-97B3-C865A764EAB5Q38597098-572979F7-217F-4179-9887-8A1791EA12A7Q38975275-F9701E4C-114B-49BB-B201-A2D7BAB88AD8Q42172458-D7D36D29-A095-4637-BA28-D1337A9372DAQ42172478-5F24F6CF-399E-4CA7-BE6A-8CA234FC95FDQ42949279-9EC9179F-22DC-4CE3-8494-50DDCD5B5304Q46116077-74D76538-061A-4D5E-9E94-68294DF07185Q47564783-FABAA541-D0FD-4EED-8041-4E24316B7D10Q47939458-BCE334FC-0379-4DCF-ADFF-957032DF422FQ47954162-1BEC3702-165A-4BAD-AB1E-CAA24A8722C4Q48408095-906E54A2-110E-4CA9-B6A8-C9F0DEBB7B45Q50048314-DDCD80E9-F730-4BED-AE66-50A691D95A28Q52650573-94A30854-1925-4F60-B3A8-6F5FD9FFE731Q53107602-8C4B0E3E-4B24-4A8D-B079-6EC7DB9370FFQ54715729-C28DA767-8739-41F4-AD4E-CA883EAF7B87
P2860
Nonhuman primate model of schizophrenia using a noninvasive EEG method.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Nonhuman primate model of schizophrenia using a noninvasive EEG method.
@ast
Nonhuman primate model of schizophrenia using a noninvasive EEG method.
@en
type
label
Nonhuman primate model of schizophrenia using a noninvasive EEG method.
@ast
Nonhuman primate model of schizophrenia using a noninvasive EEG method.
@en
prefLabel
Nonhuman primate model of schizophrenia using a noninvasive EEG method.
@ast
Nonhuman primate model of schizophrenia using a noninvasive EEG method.
@en
P2093
P2860
P356
P1476
Nonhuman primate model of schizophrenia using a noninvasive EEG method.
@en
P2093
Gene R Stoner
Raynard Fung
Ricardo Gil-da-Costa
P2860
P304
15425-15430
P356
10.1073/PNAS.1312264110
P407
P577
2013-08-19T00:00:00Z